Prediction of kidney-related outcomes in patients with type 2 diabetes

American Journal of Kidney Diseases

Volumn 60, Issue 5, 2012, Pages 770-778

  Jardine, Meg J ^a,b   Hata, Jun ^a   Woodward, Mark ^a   Perkovic, Vlado ^a   Ninomiya, Toshiharu ^a   Arima, Hisatomi ^a   Zoungas, Sophia ^a,c   Cass, Alan ^a   Patel, Anushka ^a   Marre, Michel ^d   Mancia, Giuseppe ^e   Mogensen, Carl E ^f   Poulter, Neil ^g   Chalmers, John ^a  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b ANZAC Research Institute   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d BICHAT HOSPITAL   (France)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

chronic kidney disease; Diabetic nephropathy; kidney failure; prediction model; risk score

Indexed keywords

ALBUMIN; CREATININE;

AGED; ALBUMIN CREATININE RATIO; ALBUMINURIA; ARTICLE; ASIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DEMOGRAPHY; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PROGNOSIS; RISK ASSESSMENT;

EID: 84867573681     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.04.025     Document Type: Article

References (45)

1. S. Wild, G. Roglic, A. Green, R. Sicree, H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 5 2004 1047 1053
2. US Renal Data System USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States Am J Kidney Dis 57 suppl 1 2011 e1 e526 1
3. The ANZDATA Registry The 33rd Annual Report http://www.anzdata.org.au/v1/ report-2010.html 2010 Accessed June 1, 2012
4. M.L. Sievers, R.G. Nelson, W.C. Knowler, P.H. Bennett Impact of NIDDM on mortality and causes of death in Pima Indians Diabetes Care 15 11 1992 1541 1549
5. B.J. Leavitt, L. Sheppard, C. Maloney Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery Circulation 110 suppl 1 2004 II41 II44 11
6. B.M. Brenner, M.E. Cooper, D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 2001 861 869
7. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 12 2001 851 860
8. A. Patel, S. MacMahon, J. Chalmers Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 24 2008 2560 2572
9. A. Patel, S. MacMahon, J. Chalmers Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 9590 2007 829 840
10. G.F. Strippoli, M. Craig, J.J. Deeks, F.P. Schena, J.C. Craig Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review BMJ 329 7470 2004 828
11. P. Ruggenenti, A. Fassi, A.P. Ilieva Preventing microalbuminuria in type 2 diabetes N Engl J Med 351 19 2004 1941 1951
12. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
13. J.P. Fine, R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
14. M.J. Pencina, R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 13 2004 2109 2123
15. R.B. D'Agostino, B. Nam Evaluation of the performance of survival analysis models: discrimination and calibration models Handb Stat 23 2004 1 25
16. F.E. Harrell Jr, K.L. Lee, D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
17. L.M. Sullivan, J.M. Massaro, R.B. D'Agostino Sr Presentation of multivariate data for clinical use: the Framingham Study risk score functions Stat Med 23 10 2004 1631 1660
18. R. Dhingra, M.J. Pencina, E.J. Benjamin Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy The Framingham Heart Study Am J Hypertens 17 10 2004 891 896
19. K.M. Anderson, P.M. Odell, P.W.F. Wilson, W.B. Kannel Cardiovascular disease risk profiles Am Heart J 121 1, pt 2 1991 293 298
20. M.W. Taal, B.M. Brenner Predicting initiation and progression of chronic kidney disease: developing renal risk scores Kidney Int 70 10 2006 1694 1705
21. E.S. Johnson, M.L. Thorp, R.W. Platt, D.H. Smith Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study Am J Kidney Dis 52 4 2008 653 660
22. W.F. Keane, Z. Zhang, P.A. Lyle Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL Study Clin J Am Soc Nephrol 1 4 2006 761 767
23. N. Tangri, L.A. Stevens, J. Griffith A predictive model for progression of chronic kidney disease to kidney failure JAMA 305 15 2011 1553 1559
24. Y. Foucher, P. Daguin, A. Akl A clinical scoring system highly predictive of long-term kidney graft survival Kidney Int 78 12 2010 1288 1294
25. K. Rossing, P.K. Christensen, P. Hovind, L. Tarnow, P. Rossing, H.H. Parving Progression of nephropathy in type 2 diabetic patients Kidney Int 66 4 2004 1596 1605
26. J.P. Lash, A.S. Go, L.J. Appel Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function Clin J Am Soc Nephrol 4 8 2009 1302 1311
27. A.K. Bello, J. Peters, J. Rigby Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom Clin J Am Soc Nephrol 3 5 2008 1316 1323
28. E.W. Young, E.A. Mauger, K.H. Jiang, F.K. Port, R.A. Wolfe Socioeconomic status and end-stage renal disease in the United States Kidney Int 45 3 1994 907 911
29. S.S. Merkin, A.V. Roux, J. Coresh, L.F. Fried, S.A. Jackson, N.R. Powe Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: the Cardiovascular Health Study Soc Sci Med 65 4 2007 809 821
30. S.L. White, K. McGeechan, M. Jones Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand Am J Public Health 98 7 2008 1306 1313
31. C.M. Clase, P. Gao, S.W. Tobe Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study Ann Intern Med 154 5 2011 310 318
32. S.I. Hallan, E. Ritz, S. Lydersen, S. Romundstad, K. Kvenild, S.R. Orth Combining GFR and albuminuria to classify CKD improves prediction of ESRD J Am Soc Nephrol 20 5 2009 1069 1077
33. R.T. Gansevoort, K. Matsushita, M. van der Velde Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes A collaborative meta-analysis of general and high-risk population cohorts Kidney Int 80 1 2011 93 104
34. A.S. Levey, P.E. de Jong, J. Coresh The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Kidney Int 80 1 2011 17 28
35. H. Afghahi, J. Cederholm, B. Eliasson Risk factors for the development of albuminuria and renal impairment in type 2 diabetes - the Swedish National Diabetes Register (NDR) Nephrol Dial Transplant 26 4 2011 1236 1243
36. The Microalbuminuria Collaborative Study Group Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven-year prospective study Diabet Med 16 11 1999 918 925
37. M. Svensson, G. Sundkvist, H.J. Arnqvist Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS) Diabetes Care 26 10 2003 2903 2909
38. P. Rossing, P. Hougaard, H.-H. Parving Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients Diabetes Care 25 5 2002 859 864
39. M. Ravid, D. Brosh, D. Ravid-Safran, Z. Levy, R. Rachmani Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia Arch Intern Med 158 9 1998 998 1004
40. R. Retnakaran, C.A. Cull, K.I. Thorne, A.I. Adler, R.R. Holman Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74 Diabetes 55 6 2006 1832 1838
41. H. Tanaka, Y. Shiohira, Y. Uezu, A. Higa, K. Iseki Metabolic syndrome and chronic kidney disease in Okinawa, Japan Kidney Int 69 2 2006 369 374
42. V. Perkovic, A. Cass, A.A. Patel High prevalence of chronic kidney disease in Thailand Kidney Int 73 4 2007 473 479
43. J. Chalmers, H. Arima Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE J Cardiovasc Pharmacol 55 4 2010 340 347
44. D.G. Altman, Y. Vergouwe, P. Royston, K.G. Moons Prognosis and prognostic research: validating a prognostic model BMJ 338 2009 b605
45. K.G. Moons, D.G. Altman, Y. Vergouwe, P. Royston Prognosis and prognostic research: application and impact of prognostic models in clinical practice BMJ 338 2009 b606